Literature DB >> 9815100

Role of plasmalemmal caveolae in signal transduction.

P W Shaul1, R G Anderson.   

Abstract

Caveolae are specialized plasmalemmal microdomains originally studied in numerous cell types for their involvement in the transcytosis of macromolecules. They are enriched in glycosphingolipids, cholesterol, sphingomyelin, and lipid-anchored membrane proteins, and they are characterized by a light buoyant density and resistance to solubilization by Triton X-100 at 4 degreesC. Once the identification of the marker protein caveolin made it possible to purify this specialized membrane domain, it was discovered that caveolae also contain a variety of signal transduction molecules. This includes G protein-coupled receptors, G proteins and adenylyl cyclase, molecules involved in the regulation of intracellular calcium homeostasis, and their effectors including the endothelial isoform of nitric oxide synthase, multiple components of the tyrosine kinase-mitogen-activated protein kinase pathway, and numerous lipid signaling molecules. More recent work has indicated that caveolae further serve to compartmentalize, modulate, and integrate signaling events at the cell surface. This specialized plasmalemmal domain warrants direct consideration in future investigations of both normal and pathological signal transduction in pulmonary cell types.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9815100     DOI: 10.1152/ajplung.1998.275.5.L843

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  140 in total

1.  A scaffolding for regulation of volume-sensitive Cl- channels.

Authors:  Y Okada
Journal:  J Physiol       Date:  1999-10-01       Impact factor: 5.182

Review 2.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

3.  Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules.

Authors:  J Guignot; M F Bernet-Camard; C Poüs; L Plançon; C Le Bouguenec; A L Servin
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 4.  Caveolae: an alternative membrane transport compartment.

Authors:  M Gumbleton; A G Abulrob; L Campbell
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

5.  Differential caveolin-1 polarization in endothelial cells during migration in two and three dimensions.

Authors:  Marie-Odile Parat; Bela Anand-Apte; Paul L Fox
Journal:  Mol Biol Cell       Date:  2003-05-03       Impact factor: 4.138

Review 6.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

Review 7.  Sphingosine-1-phosphate and modulation of vascular tone.

Authors:  Junsuke Igarashi; Thomas Michel
Journal:  Cardiovasc Res       Date:  2009-02-20       Impact factor: 10.787

8.  Caveolin-induced activation of the phosphatidylinositol 3-kinase/Akt pathway increases arsenite cytotoxicity.

Authors:  Sonsoles Shack; Xian-Tao Wang; Gertrude C Kokkonen; Myriam Gorospe; Dan L Longo; Nikki J Holbrook
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  Analysis of Stat3 (signal transducer and activator of transcription 3) dimerization by fluorescence resonance energy transfer in living cells.

Authors:  Antje K Kretzschmar; Michaela C Dinger; Christian Henze; Katja Brocke-Heidrich; Friedemann Horn
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

10.  Cell surface orifices of caveolae and localization of caveolin to the necks of caveolae in adipocytes.

Authors:  Hans Thorn; Karin G Stenkula; Margareta Karlsson; Unn Ortegren; Fredrik H Nystrom; Johanna Gustavsson; Peter Stralfors
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.